A New Way Forward in Cancer Drug Discovery: Inhibiting the SWI/SNF Chromatin Remodelling Complex
- PMID: 26684344
- DOI: 10.1002/cbic.201500565
A New Way Forward in Cancer Drug Discovery: Inhibiting the SWI/SNF Chromatin Remodelling Complex
Abstract
Mutations in subunits of the SWI/SNF chromatin remodelling complex are found in 20 % of human cancers. At face value, this would appear to indicate that this multiprotein complex is a potent tumour suppressor. However, it has recently emerged that some mutations in the SWI/SNF complex can have a gain-of-function effect and that in other tumours, such as pancreatic cancer, leukaemia, and breast cancer, the wild-type complex is used to drive cancer. Thus, paradoxically, this "tumour suppressor" has become an attractive target for developing anticancer agents. The SWI/SNF complex makes several protein-protein interactions both within the complex and with a wide range of transcription factors, and targeting these protein-protein interactions is emerging as the best approach to modulating the activity of the complex selectively.
Keywords: SWI/SNF complexes; cancer; epigenetics; transcription factors.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.Oncogene. 2021 May;40(21):3637-3654. doi: 10.1038/s41388-021-01781-x. Epub 2021 May 3. Oncogene. 2021. PMID: 33941852 Free PMC article. Review.
-
Chromatin remodellers as therapeutic targets.Nat Rev Drug Discov. 2024 Sep;23(9):661-681. doi: 10.1038/s41573-024-00978-5. Epub 2024 Jul 16. Nat Rev Drug Discov. 2024. PMID: 39014081 Review.
-
BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?Epigenetics Chromatin. 2019 Nov 13;12(1):68. doi: 10.1186/s13072-019-0315-4. Epigenetics Chromatin. 2019. PMID: 31722744 Free PMC article. Review.
-
A rationale to target the SWI/SNF complex for cancer therapy.Trends Genet. 2014 Aug;30(8):356-63. doi: 10.1016/j.tig.2014.05.001. Epub 2014 Jun 3. Trends Genet. 2014. PMID: 24932742 Free PMC article. Review.
-
Advances in the role of SWI/SNF complexes in tumours.J Cell Mol Med. 2023 Apr;27(8):1023-1031. doi: 10.1111/jcmm.17709. Epub 2023 Mar 8. J Cell Mol Med. 2023. PMID: 36883311 Free PMC article. Review.
Cited by
-
The structure of INI1/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI/SNF chromatin remodeling complex.FEBS J. 2018 Nov;285(22):4165-4180. doi: 10.1111/febs.14660. Epub 2018 Oct 1. FEBS J. 2018. PMID: 30222246 Free PMC article.
-
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment.Cell Mol Immunol. 2020 Sep;17(9):940-953. doi: 10.1038/s41423-020-0505-9. Epub 2020 Jul 22. Cell Mol Immunol. 2020. PMID: 32699350 Free PMC article. Review.
-
Domain architecture of BAF250a reveals the ARID and ARM-repeat domains with implication in function and assembly of the BAF remodeling complex.PLoS One. 2018 Oct 11;13(10):e0205267. doi: 10.1371/journal.pone.0205267. eCollection 2018. PLoS One. 2018. PMID: 30307988 Free PMC article.
-
Structure and DNA binding analysis of AT-rich interaction domain present in human BAF-B specific subunit BAF250b.Protein Sci. 2022 May;31(5):e4294. doi: 10.1002/pro.4294. Protein Sci. 2022. PMID: 35481652 Free PMC article.
-
Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?Gut. 2017 Jan;66(1):168-179. doi: 10.1136/gutjnl-2016-312539. Epub 2016 Nov 3. Gut. 2017. PMID: 27811314 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
